Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis

被引:475
作者
Dwyer, JH
Allayee, H
Dwyer, KM
Fan, J
Wu, HY
Mar, R
Lusis, AJ
Mehrabian, M
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA USA
[3] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA
关键词
D O I
10.1056/NEJMoa025079
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Leukotrienes are inflammatory mediators generated from arachidonic acid (polyunsaturated n-6 fatty acid) by the enzyme 5-lipoxygenase. Since atherosclerosis involves arterial inflammation, we hypothesized that a polymorphism in the 5-lipoxygenase gene promoter could relate to atherosclerosis in humans and that this effect could interact with the dietary intake of competing 5-lipoxygenase substrates. METHODS: We determined 5-lipoxygenase genotypes, carotid-artery intima-media thickness, and markers of inflammation in a randomly sampled cohort of 470 healthy, middle-aged women and men from the Los Angeles Atherosclerosis Study. Dietary arachidonic acid and marine n-3 fatty acids (including a competing 5-lipoxygenase substrate that reduces the production of inflammatory leukotrienes) were measured with the use of six 24-hour recalls of food intake. RESULTS: Variant 5-lipoxygenase genotypes (lacking the common allele) were found in 6.0 percent of the cohort. Mean (+/-SE) intima-media thickness adjusted for age, sex, height, and racial or ethnic group was increased by 80+/-19 microm (95 percent confidence interval, 43 to 116; P<0.001) among carriers of two variant alleles, as compared with carriers of the common (wild-type) allele. In multivariate analysis, the increase in intima-media thickness among carriers of two variant alleles (62 microm, P<0.001) was similar in this cohort to that associated with diabetes (64 microm, P=0.01), the strongest common cardiovascular risk factor. Increased dietary arachidonic acid significantly enhanced the apparent atherogenic effect of genotype, whereas increased dietary intake of n-3 fatty acids blunted the effect. Finally, the plasma level of C-reactive protein, a marker of inflammation, was increased by a factor of 2 among carriers of two variant alleles as compared with that among carriers of the common allele. CONCLUSIONS: Variant 5-lipoxygenase genotypes identify a subpopulation with increased atherosclerosis. The observed diet-gene interactions further suggest that dietary n-6 polyunsaturated fatty acids promote, whereas marine n-3 fatty acids inhibit, leukotriene-mediated inflammation that leads to atherosclerosis in this subpopulation.
引用
收藏
页码:29 / 37
页数:9
相关论文
共 50 条
[1]   Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice [J].
Aiello, RJ ;
Bourassa, PA ;
Lindsey, S ;
Weng, WF ;
Freeman, A ;
Showell, HJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (03) :443-449
[2]   Blood levels of long-chain n-3 fatty acids and the risk of sudden death. [J].
Albert, CM ;
Campos, H ;
Stampfer, MJ ;
Ridker, PM ;
Manson, JE ;
Willett, WC ;
Ma, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15) :1113-1118
[3]   Differential leukotriene constrictor responses in human atherosclerotic coronary arteries [J].
Allen, S ;
Dashwood, M ;
Morrison, K ;
Yacoub, M .
CIRCULATION, 1998, 97 (24) :2406-2413
[4]  
Andreotti F, 1999, Cardiologia, V44, P341
[5]   Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction [J].
Boekholdt, SM ;
Bijsterveld, NR ;
Moons, AHM ;
Levi, M ;
Büller, HR ;
Peters, RJG .
CIRCULATION, 2001, 104 (25) :3063-3068
[6]   Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice [J].
Burleigh, ME ;
Babaev, VR ;
Oates, JA ;
Harris, RC ;
Gautam, S ;
Riendeau, D ;
Marnett, LJ ;
Morrow, JD ;
Fazio, S ;
Linton, MF .
CIRCULATION, 2002, 105 (15) :1816-1823
[7]   Assessment of individual fatty acid intake [J].
Cantwell, MM .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2000, 59 (02) :187-191
[8]   The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice - Evidence that eicosanoids other than thromboxane contribute to atherosclerosis [J].
Cayatte, AJ ;
Du, Y ;
Oliver-Krasinski, J ;
Lavielle, G ;
Verbeuren, TJ ;
Cohen, RA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (07) :1724-1728
[9]  
Cyrus T, 2001, CIRCULATION, V103, P2277
[10]   Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment [J].
Drazen, JM ;
Yandava, CN ;
Dubé, L ;
Szczerback, N ;
Hippensteel, R ;
Pillari, A ;
Israel, E ;
Schork, N ;
Silverman, ES ;
Katz, DA ;
Drajesk, J .
NATURE GENETICS, 1999, 22 (02) :168-170